Skip to main content
Caplight Logo









Tessellate BIO

Tessellate BIO

Private
NaardenHealthcare & Life Scienceshttps://tessellatebio.com/

Last Round

Seed

Oct 17, 2023

Total Funding Raised

$8.4M

Company Overview

Tessellate BIO is a biotechnology company that discovers and develops novel precision oncology medicines with a focus on synthetic lethality.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

synthetic lethalityprecision oncologysmall molecule drugsdrug discoveryALT inhibitorsAlternative Lengthening of TelomeresALTpreclinical biotechbiotech startupcompanion diagnosticsCDxRB1 loss-of-functionpharma partnershipsbiotech licensingbiomarker discoverybioinformatics platform

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Tessellate BIO Comparables

Compare Tessellate BIO with similar companies based on industry and business-model similarity.

Tessellate BIO comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ALTx Therapeutics
88%
Breakpoint Therapeutics
80%
Nodus Oncology
79%

Tessellate BIO Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 17, 2023

Key People

Founding team and executive leadership

Andree Blaukat

CEO

Executive Team

Tessellate BIO Investors

Notable investors and investment history

Tessellate BIO investors
InvestorRounds
ForbionSeed
BioGeneration VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 8, 2025

    Monthly visitors grew 84% MoM, reaching 1.3K.

  • May 2, 2025

    Monthly visitors grew 160% MoM, reaching 2.6K.

Tessellate BIO Filings

Explore SEC and related filing metadata, where available.

Tessellate BIO filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Tessellate BIO's valuation, stock price, and market status.

Is Tessellate BIO a public or private company?

Tessellate BIO is a private company.

What is the current stock price of Tessellate BIO?

Tessellate BIO is a private company with no public stock price. No recent secondary market data is available.

How much is Tessellate BIO worth (valuation)?

Valuation information for Tessellate BIO is not publicly available.

Can I buy Tessellate BIO stock?

Tessellate BIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Tessellate BIO's last funding round?

Funding round information for Tessellate BIO is not publicly available.

Who are the main investors in Tessellate BIO?

Investor information for Tessellate BIO is not publicly disclosed.

Will Tessellate BIO IPO soon?

No public IPO plans have been announced for Tessellate BIO.

How can I track Tessellate BIO secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Tessellate BIO's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNaarden
Employee Range23
Year Founded2022
Last FundingOct 17, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?